Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The version history shows internal revision updates with v3.3.2 added and v3.2.0 removed, which do not affect trial data or public content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:57:34.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site-wide government funding/operating status notice has been removed from the page header. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:21:41.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    On 2025-10-29, the record was updated to include a Results Posted entry, adding the Results, Outcome Measures, and Study Status details. The 2025-07-08 entry for 'Results Submitted' was removed, and the 2025-10-15 version 36 consolidates these updates.
    Difference
    0.5%
    Check dated 2025-11-03T21:25:13.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    10%
    Check dated 2025-10-06T06:36:41.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.2%
    Check dated 2025-09-29T03:15:13.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    New substantial study-status and outcome-measures content added, including sections for participant flow, baseline characteristics, results, adverse events, quality control, and a return date.
    Difference
    3%
    Check dated 2025-09-22T00:13:21.000Z thumbnail image

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.